Semaglutide Dosage Chart for Weight Loss (mg and Units)

The standard week-by-week semaglutide schedule, how to convert mg to syringe units, and what to do if you miss a dose.

By

NativeMed

Medically reviewed by

Dr. Michael Wasef, MD

Published

· Last reviewed

Semaglutide dosage chart showing weekly doses rising from 0.25 mg to 2.4 mg over 17 weeks

Key Takeaways

  • The standard weight-loss schedule starts at 0.25 mg once a week and rises every 4 weeks to a 2.4 mg target dose.

  • Once you reach your goal, your provider may lower your dose to the lowest one that keeps your weight stable.

  • To convert mg to syringe units: dose in mg ÷ vial concentration in mg/mL × 100. Concentration varies by pharmacy, so always check your label.

  • Compounded semaglutide has no official dosing chart. Always follow your prescription label.

Semaglutide is started at a low dose and raised in steps over about four months. The low start gives your body time to adjust and makes stomach side effects less likely. This guide shows the standard week-by-week schedule, how to read your vial, how milligrams (mg) convert to syringe units, and what to do if you miss a dose.

Important: this chart is general information, not a prescription. Your provider decides your dose and when it changes. Always follow your provider's instructions and your prescription label.

Semaglutide dosage chart for weight loss

The schedule below comes from the FDA-approved prescribing information for Wegovy (semaglutide injection), the branded medication for chronic weight management. Doses are taken once a week, on the same day each week.

Standard semaglutide dosing schedule for weight loss (Wegovy label)

Weeks

Weekly dose

Stage

1–4

0.25 mg

Starting dose

5–8

0.5 mg

Increase

9–12

1 mg

Increase

13–16

1.7 mg

Increase

17 onward

2.4 mg

Target dose

The early doses are for getting used to the medication. In March 2026, the FDA also approved a higher 7.2 mg dose (Wegovy HD) for adults who have tolerated 2.4 mg for at least 4 weeks and need more weight reduction.

Once you reach your goal, your provider may lower your dose to find the lowest dose that keeps your weight stable. If you start regaining weight, your dose may need to go back up.

Compounded semaglutide is not FDA-approved, and there is no official dosing chart for it. Providers who prescribe it usually follow a similar gradual schedule, but doses and schedules can differ by pharmacy. Always follow your prescription label.

Weight loss dosing vs diabetes dosing

Semaglutide is also sold as Ozempic, which is FDA-approved for type 2 diabetes, not weight loss. Its schedule starts the same way, at 0.25 mg weekly for 4 weeks, then 0.5 mg. After that, the dose can go up to 1 mg and a maximum of 2 mg weekly. That's why charts online sometimes stop at 2 mg: they are showing the diabetes schedule, not the weight-loss one.

What the research shows at 2.4 mg

In the STEP 1 trial, adults with obesity or overweight took branded semaglutide 2.4 mg weekly for 68 weeks, along with diet and activity changes. They lost an average of 14.9% of their body weight, compared with 2.4% for people on placebo. These results come from the FDA-approved branded medication. There are no comparable trials of compounded semaglutide, and individual results vary.

How to read your vial label

Your vial label shows two different numbers, and mixing them up is the most common cause of dosing mistakes:

  • Concentration is how much semaglutide is in each milliliter (mL) of liquid, for example 2.5 mg/mL. It describes the vial and stays the same for the whole vial.

  • Your dose is how much semaglutide you take each week, for example 0.5 mg. It comes from your prescription and changes as your provider adjusts it.

You need both numbers to work out how many units to draw. The same 0.5 mg dose can be 20 units from one vial and 50 units from another, depending on the concentration.

What your medication should look like: a reddish color means your vial contains the B12 additive, and a clear liquid means it does not. Both are normal. If the liquid is cloudy, has particles, or doesn't match your prescription, stop and contact support.

Semaglutide mg to units conversion

You draw each dose with a U-100 insulin syringe, where 1 unit equals 0.01 mL. The formula is: units = dose in mg ÷ concentration in mg/mL × 100

Semaglutide mg to units on a U-100 syringe, by vial concentration

Dose

1 mg/mL

2.5 mg/mL

5 mg/mL

0.25 mg

25 units

10 units

5 units

0.5 mg

50 units

20 units

10 units

1 mg

100 units

40 units

20 units

1.7 mg

170 units*

68 units

34 units

2.4 mg

240 units*

96 units

48 units

*More than one 100-unit syringe. Units are for a U-100 insulin syringe.

Example: if your vial says 2.5 mg/mL and your dose is 0.5 mg, the math is 0.5 ÷ 2.5 × 100 = 20 units.

Measure carefully. A small misreading can cause a large dosing error. FDA has received reports of patients drawing 50 units instead of 5. If you are unsure, ask your provider or pharmacist before injecting.

Why the dose starts low

Semaglutide slows how quickly your stomach empties and reduces appetite. The most common side effects are digestive: nausea, diarrhea, vomiting, constipation and stomach pain. They are most likely when you start the medication or move up a dose.

Increasing the dose slowly gives your body time to adjust, which is why the standard schedule spends at least four weeks at each step. If side effects are hard to manage, providers often keep you at your current dose for longer before increasing, or lower the dose for a while.

How long to stay on each dose

In the standard schedule, each step lasts four weeks. That's a minimum, not a deadline: some people stay at a dose for several months, especially if they are losing weight steadily and tolerating it well. The goal is the dose that works for you with manageable side effects, not the highest dose possible.

What to do if you miss a dose

The Wegovy prescribing information gives this guidance for a single missed weekly dose:

  • If your next scheduled dose is more than 2 days away, take the missed dose as soon as you remember.

  • If your next scheduled dose is less than 2 days away, skip the missed dose and take the next one on your usual day.

If you have missed 2 or more doses in a row, contact your provider before your next dose. If you have been off the medication for less than 4 weeks, you can usually resume the same dose. From 4 to 8 weeks, you would restart one dose step lower. From 8 to 12 weeks, you would restart at the second dose step. After more than 12 weeks, you would restart at the first dose step.

If you take too much

Extra medication most often causes mild stomach side effects. If nausea, vomiting or abdominal discomfort keeps getting worse, go to urgent care because this can be pancreatitis. Never double up on doses.

If you believe you took more than prescribed, contact your healthcare provider promptly. You may also contact Poison Control at 1-800-222-1222. For severe or life-threatening symptoms, call 911 or seek emergency medical attention.

Handling and storing your vial

Use a new needle and syringe for every dose. Discard the vial by the date from your pharmacy or 28 days after first use, whichever comes first. If your medication arrives warm, contact the pharmacy or support before using it.

What about microdosing?

Microdosing means taking lower doses of a GLP-1 medication than the standard schedule. There is little clinical research on this approach, so talk to your provider rather than adjusting your own dose.

Important safety information

Do not use this medication if you or a family member has had medullary thyroid cancer, or if you have MEN 2. Do not use it during pregnancy or while breastfeeding, and stop at least 2 months before a planned pregnancy. Tell your provider if you use insulin or other diabetes medications, because they can increase the risk of low blood sugar.

Get emergency care for severe abdominal pain, especially pain that spreads to your back. Call 911 for trouble breathing or swelling of your face, lips or tongue. Tell your provider right away about a neck lump, hoarseness, trouble swallowing, or thoughts of harming yourself.

See the full Important Safety Information.

How dosing works at NativeMed

At NativeMed, a licensed U.S. provider reviews your intake and medical history and decides whether compounded semaglutide is appropriate for you. Before treatment, you'll be asked to give your consent to treatment with a compounded medication. If it's prescribed, the provider sets your starting dose and adjusts it over time based on how you respond.

Plans start from $149 a month, at the same price for any dose. If prescribed, your medication is prepared by a licensed U.S. compounding pharmacy and ships free. See compounded semaglutide plans.

Compounded medications are not approved by the FDA, and the FDA does not review them for safety, effectiveness or quality before they are dispensed. Individual results vary.

Frequently asked questions

How many units is 0.25 mg of semaglutide?

It depends on your vial's concentration. At 2.5 mg/mL, 0.25 mg is 10 units on a U-100 insulin syringe. At 1 mg/mL it is 25 units, and at 5 mg/mL it is 5 units. Always check your vial label.

How long should you stay on each dose of semaglutide?

The standard schedule moves up every 4 weeks. That is a minimum: many people stay on a dose longer if it is working or if side effects need time to settle. Your provider decides when to increase.

What is the maximum dose of semaglutide for weight loss?

In the Wegovy label, the standard schedule goes up to 2.4 mg once weekly. In March 2026 the FDA also approved a 7.2 mg dose (Wegovy HD) for adults who have tolerated 2.4 mg for at least 4 weeks and need more weight reduction. For compounded semaglutide, follow your prescription.

What happens if you increase the semaglutide dose too fast?

Digestive side effects such as nausea, vomiting and diarrhea become more likely. That is why the dose is raised gradually, and why providers often hold or lower the dose if side effects are hard to manage.

What should I do if I'm sick?

Hold your next injection until you have recovered.

What results should I expect?

Little weight loss is common in the first 2 months. A safe target is about 3 to 5 pounds per month.

Can I switch between semaglutide and tirzepatide?

Yes, but do not convert the dose yourself. You will need a new prescription, and the two medications should not overlap. The mg numbers are not comparable between them.

Dr. Michael Wasef, MD, Board-Certified Internal Medicine Physician

Medically reviewed by

Dr. Michael Wasef, MD

Board-Certified Internal Medicine Physician

Limited time discount on

your first order

Sign up to receive health tips and more.

NativeMed may facilitate access to compounded medications when prescribed by a licensed healthcare provider and dispensed by a licensed compounding pharmacy. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA), and the FDA does not review compounded medications for safety, effectiveness, or quality before they are dispensed. Compounded medications are prepared for individual patients based on a provider’s medical judgment and are not generic versions of, therapeutically equivalent to, or substitutes for FDA-approved medications such as MOUNJARO®, ZEPBOUND™, Wegovy®, or Ozempic®. NativeMed does not manufacture medications, practice medicine, or determine whether a specific medication is appropriate for you. Treatment decisions are made by licensed healthcare providers after reviewing your medical history, eligibility, and treatment goals. Information provided by NativeMed is for educational purposes only and should not be interpreted as a claim that any compounded medication is FDA-approved, clinically proven, equivalent to an FDA-approved drug, or guaranteed to produce a specific result, including weight loss. Individual results vary. All medications carry risks, potential side effects, and contraindications and should be used only as prescribed under the supervision of a licensed healthcare provider.

IMPORTANT SAFETY INFORMATION

Copyright © 2026 NativeMed

|

All Rights Reserved

|

|

|

|

|

|

|

|

Limited time discount

on

your first order

Sign up to receive health tips and more.

|

NativeMed may facilitate access to compounded medications when prescribed by a licensed healthcare provider and dispensed by a licensed compounding pharmacy. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA), and the FDA does not review compounded medications for safety, effectiveness, or quality before they are dispensed. Compounded medications are prepared for individual patients based on a provider’s medical judgment and are not generic versions of, therapeutically equivalent to, or substitutes for FDA-approved medications such as MOUNJARO®, ZEPBOUND™, Wegovy®, or Ozempic®. NativeMed does not manufacture medications, practice medicine, or determine whether a specific medication is appropriate for you. Treatment decisions are made by licensed healthcare providers after reviewing your medical history, eligibility, and treatment goals. Information provided by NativeMed is for educational purposes only and should not be interpreted as a claim that any compounded medication is FDA-approved, clinically proven, equivalent to an FDA-approved drug, or guaranteed to produce a specific result, including weight loss. Individual results vary. All medications carry risks, potential side effects, and contraindications and should be used only as prescribed under the supervision of a licensed healthcare provider.

IMPORTANT SAFETY INFORMATION

|

|

|

|

|

|

Copyright © 2026 NativeMed

All Rights Reserved

Limited time discount on

your first order

Sign up to receive health tips and more.

|

NativeMed may facilitate access to compounded medications when prescribed by a licensed healthcare provider and dispensed by a licensed compounding pharmacy. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA), and the FDA does not review compounded medications for safety, effectiveness, or quality before they are dispensed. Compounded medications are prepared for individual patients based on a provider’s medical judgment and are not generic versions of, therapeutically equivalent to, or substitutes for FDA-approved medications such as MOUNJARO®, ZEPBOUND™, Wegovy®, or Ozempic®. NativeMed does not manufacture medications, practice medicine, or determine whether a specific medication is appropriate for you. Treatment decisions are made by licensed healthcare providers after reviewing your medical history, eligibility, and treatment goals. Information provided by NativeMed is for educational purposes only and should not be interpreted as a claim that any compounded medication is FDA-approved, clinically proven, equivalent to an FDA-approved drug, or guaranteed to produce a specific result, including weight loss. Individual results vary. All medications carry risks, potential side effects, and contraindications and should be used only as prescribed under the supervision of a licensed healthcare provider.

IMPORTANT SAFETY INFORMATION

|

|

|

|

|

|

Copyright © 2026 NativeMed

|

All Rights Reserved